Progenitor cell release plus exercise to improve functional performance in peripheral artery disease: The PROPEL Study

Contemporary Clinical Trials

Volumn 36, Issue 2, 2013, Pages 502-509

  Domanchuk, Kathryn ^a   Ferrucci, Luigi ^b   Guralnik, Jack M ^c   Criqui, Michael H ^d   Tian, Lu ^e   Liu, Kiang ^a   Losordo, Douglas ^a   Stein, James ^f   Green, David ^a   Kibbe, Melina ^a,g   Zhao, Lihui ^a   Annex, Brian ^h   Perlman, Harris ^a   Lloyd Jones, Donald ^a   Pearce, William ^a   Taylor, Doris ⁱ   McDermott, Mary M ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e STANFORD UNIVERSITY   (United States)

^f UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^g JESSE BROWN VA MEDICAL CENTER   (United States)

^h UNIVERSITY OF VIRGINIA   (United States)

ⁱ TEXAS HEART INSTITUTE   (United States)

Author keywords

GM CSF; Intermittent claudication; Peripheral vascular disease; Physical functioning; Stem cells

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; PLACEBO;

ARTERY BLOOD FLOW; ARTICLE; BRACHIAL ARTERY; HUMAN; KINESIOTHERAPY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STEM CELL; TREADMILL; TREADMILL EXERCISE; WALKING;

GM-CSF; INTERMITTENT CLAUDICATION; PERIPHERAL VASCULAR DISEASE; PHYSICAL FUNCTIONING; STEM CELLS;

ANKLE BRACHIAL INDEX; COMBINED MODALITY THERAPY; EXERCISE THERAPY; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; TREATMENT OUTCOME; WALKING;

EID: 84885936001     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2013.09.011     Document Type: Article

References (56)

1. Go A.S., Mozaffarian D., Roger V.L., Benjamin E.J., Berry J.D., Borden W.B., et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2013 Update: A Report from the American Heart Association. Circulation 2013, 127:e6-e245.
2. McDermott M.M., Greenland P., Liu K., Guralnik J.M., Criqui M.H., Dolan N.C., et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA Oct 3 2001, 286(13):1599-1606.
3. McDermott M.M., Liu K., Greenland P., Guralnik J.M., Criqui M.H., Chan C., et al. Functional decline in peripheral arterial disease: associations with the ankle brachial index and leg symptoms. JAMA Jul 28 2004, 292(4):453-461.
4. McDermott M.M., Greenland P., Liu K., Guralnik J.M., Celic L., Criqui M.H., et al. The ankle brachial index is associated with leg function and physical activity: the Walking and Leg Circulation Study. Ann Intern Med Jun 18 2002, 136(12):873-883.
5. McDermott M.M., Guralnik J.M., Tian L., Ferrucci L., Liu K., Liao Y., et al. Baseline functional performance predicts the rate of mobility loss in peripheral arterial disease. J Am Coll Cardiol 2007, 50:974-982.
6. Dawson D.L., Cutler B.S., Meissner M.H., Strandness D.E.J. Cilostazol has beneficial effects in treatment of intermittent claudication: results from a multi-center, randomized, prospective, double-blind trial. Circulation 1998, 98:678-686.
7. Money S.R., Herd J.A., Isaacsohn J.L., Davidson M., Cutler B., Heckman J., et al. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease. J Vasc Surg 1998, 27:267-274.
8. Beebe H.G., Dawson D.L., Cutler B.S., Herd J.A., Strandness D.E., Bortey E.B., et al. A new pharmacological treatment for intermittent claudication: results of a randomized, multi-center trial. Arch Intern Med 1999, 159:2041-2050.
9. Girolami B., Bernardi E., Prins M.H., Ten Cate J.W., Hettiarachchi R., Prandoni P., et al. Treatment of intermittent claudication with physical training, smoking cessation, pentoxifylline, or nafronyl: a meta-analysis. Arch Intern Med 1999, 159:337-345.
10. Laufs U., Werner N., Link A., Endres M., Wassmann S., Jürgens K., et al. Physical training increases endothelial progenitor cells, inhibits neointima formation, and enhances angiogenesis. Circulation 2004, 109:220-226.
11. Subramaniyam V., Waller E.K., Murrow J.R., Manatunga A., Lonial S., Kasirajan K., et al. Bone marrow mobilization with granulocyte macrophage colony-stimulating factor improves endothelial dysfunction and exercise capacity in patients with peripheral arterial disease. Am Heart J 2009, 158:53-60.
12. Sandri M., Adams V., Gielen S., Linke A., Lenk K., Kränkel N., et al. Effects of exercise and ischemia on mobilization and functional activation of blood-derived progenitor cells in patients with ischemic syndromes: results of 3 randomized studies. Circulation 2005, 111:3391-3399.
13. Ben-Shoshan J., George J. Endothelial progenitor cells as therapeutic vector in cardiovascular disorders: from experimental models to human trials. Pharmacol Ther 2007, 25-36.
14. Takahashi T., Kalka C., Masuda H., Chen D., Silver M., Kearney M., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999, 5:434-438.
15. Takazoe M., Matsui T., Motoya S., Matsumoto T., Hibi T., Watanabe M. Sargramostim in patients with Crohn's disease: results of a phase 1-2 study. J Gastroenterol 2009, 44:535-543.
16. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997, 275:964-967.
17. Murasawa S., Asahara T. Cardiogenic potential of endothelial progenitor cells. Ther Adv Cardiovasc Dis Oct 2008, 2(5):341-348.
18. Thijssen D.H.J., Torella D., Hopman M.T.E., Ellison G.M. The role of endothelial progenitor and cardiac stem cells in the cardiovascular adaptations to age and exercise. Front Biosci 2009, 14:4685-4702.
19. Van Royen N., Schirmer S.H., Atasever B., Behrens C.Y.H., Ubbink D., Buschmann E.E., et al. START Trial: a pilot study on stimulation or ARTeriogenesis using subcutaneous application of granulocyte-macrophage colony stimulating factor as a new treatment for peripheral arterial disease. Circulation 2005, 112:1040-1046.
20. Arai M., Misao Y., Nagai H., Kawasaki M., Nagashima K., Suzuki K., et al. Granulocyte colony-stimulating factor: a noninvasive regeneration therapy for treating atherosclerotic peripheral arterial disease. Circ J 2006, 70:1093-1098.
21. McDermott M.M., Ades P., Guralnik J.M., Dyer A., Ferrucci L., Liu K., et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA 2009, 301(2):165-174. [PMID: 19141764].
22. Fadini G.P., Sartore S., Albiero M., Baesso I., Murphy E., Menegolo M., et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol Sep 2006, 26(9):2140-2146.
23. Fadini G.P., Miorin M., Facco M., Bonamico S., Baesso I., Grego F., et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol May 3 2005, 45(9):1446-1457.
24. Parmenter B.J., Raymond J., Fiatarone Singh M.A. The effect of exercise on fitness and performance-based tests of function in intermittent claudication: a systematic review. Sports Med 2013, 43:513-524.
25. Gardner A.W., Katzel L.I., Sorkin J.D., Bradham D.D., Hochberg M.C., Flinn W.R., et al. Exercise rehabilitation improves functional outcomes and peripheral claudication in patients with intermittent claudication: a randomized controlled trial. J Am Geriatr Soc 2001, 49:755-762.
26. Tsai J.C., Chan P., Wang C.H., Jeng C., Hsieh M.H., Kao P.F., et al. The effects of exercise training on walking function and perception of health status in elderly patients with peripheral arterial occlusive disease. J Intern Med 2002, 252:448-455.
27. Amirhamzeh M.M., Chant H.J., Rees J.L., Hands L.J., Powell R.J., Campbell W.B. A comparative study of treadmill tests and heel raising exercise for peripheral arterial disease. Eur J Vasc Endovasc Surg 1997, 13:301-305.
28. McDermott M.M., Liu K., Guralnik J.M., Criqui M.H., Spring B., Tian L., et al. Home-based walking exercise intervention in peripheral artery disease. JAMA 2013, 310:57-65.
29. McDermott M.M., Tian L., Liu K., Guralnik J.M., Ferrucci L., Tan J., et al. Prognostic value of functional performance for mortality in patients with peripheral artery disease. J Am Coll Cardiol 2008, 51(15):1482-1489.
30. McDermott M.M., Guralnik J.M., Tian L., Ferrucci L., Liu K., Liao Y., et al. Baseline functional performance predicts the rate of mobility loss in persons with peripheral arterial disease. J Am Coll Cardiol 2007, 50(10):974-982.
31. McDermott M.M., Liu K., Ferrucci L., Tian L., Guralnik J.M., Liao Y., et al. Decline in functional performance predicts later increased mobility loss and mortality in peripheral arterial disease. J Am Coll Cardiol 2011, 57(8):962-970.
32. McDermott M.M., Ades P.A., Dyer A., Gurlanik J.M., Kibbe M., Criqui M.H. Corridor-based functional performance measures correlate better with physical activity during daily life than treadmill measures in persons with peripheral arterial disease. J Vasc Surg February 22 2008, 48:1231-1237. [PMID: 18829215].
33. Greig C., Butler F., Skelton D., Mahmud S., Young A. Treadmill walking in old age may not reproduce the real life situation. J Am Geriatr Soc 1993, 41:15-18.
34. Swerts P.M.J., Mostert R., Wouters E.F.M. Comparison of corridor and treadmill walking in patients with severe chronic obstructive pulmonary disease. Phys Ther 1990, 70:439-442.
35. Peeters P., Mets T. The six-minute walk as an appropriate exercise test in elderly patients with chronic heart failure. J Gerontol Med Sci 1996, 51A:M147-M151.
36. Gardner A.W., Skinner J.S., Cantwell B.W., Smith L.K. Progressive vs. single-stage treadmill tests for evaluation of claudication. Med Sci Sports Exerc 1991, 23:402-408.
37. Gardner A.W., Skinner J.S., Cantwell B.W., Smith L.K. Effects of handrail support on claudication and hemodynamic responses to single-stage and progressive treadmill protocols in peripheral vascular occlusive disease. Am J Cardiol 1991, 67:99-105.
38. Hiatt W.R., Regensteiner J.G., Hargarten M.E., Wolfel E.E., Brass E.P. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation 1990, 81:602-609.
39. Montgomery P.S., Gardner A.W. The clinical utility of a six-minute walk test in peripheral arterial occlusive disease patients. J Am Geriatr Soc 1998, 46:706-711.
40. Corretti M.C., Anderson T.J., Benjamin E.J., Celermajer D., Charbonneau F., Creager M.A., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002, 39(2):257-265.
41. Devanesan A.J., Laughlan K.A., Girn H.R.S., Homer-Vanniaskinkam S. Endothelial progenitor cells as a therapeutic option in peripheral arterial disease. Eur J Vasc Endovasc Surg 2009, 38:475-481.
42. Ishida A., Ohya Y., Sakuda H., Ohshiro K., Higashiuesato Y., Nakaema M., et al. Autologous peripheral blood mononuclear cell implantation for patients with peripheral arterial disease improves limb ischemia. Circ J 2005, 69:1260-1265.
43. Kawamoto A., Katayama M., Handa N., Kinoshita M., Takano H., Horii M., et al. Intramuscular transplantation of G-CSF-Mobilized CD34+ cells in patients with critical limb ischemia: A Phase I/IIa, Multicenter, Single-blinded, dose-escalation clinical trial. Stem Cells 2009, 27:2857-2864.
44. Fadini G.P., Miorin M., Facco M., Bonamico S., Baesso I., Grego F., et al. Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol 2005, 45:1449-1457.
45. Fadini G.P., Sartore S., Albiero M., Baesso I., Murphy E., Menegolo M., et al. Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol 2006, 26:2140-2146.
46. Noble B.J. Clinical applications of perceived exertion. Med Sci Sports Exerc 1982, 14(5):406-411.
47. Perera S., Mody S.H., Woodman R.C., Studenski S.A. Meaningful change and responsiveness in common physical performance measures in older adults. J Am Geriatr Soc 2006, 54:743-749.
48. Regensteiner J.G., Meyer T.J., Krupski W.C., Cranford L.S., Hiatt W.R. Hospital vs. home-based exercise rehabilitation for patients with peripheral arterial occlusive disease. Angiology 1997, 48:291-300.
49. Collins T.C., Lunos S., Carlson T., Henderson K., Lightbourne M., Nelson B., et al. Effects of a home-based walking intervention on mobility and quality of life in people with diabetes and peripheral arterial disease. Diabetes Care 2011, 34:2174-2179.
50. Gardner A.W., Parker D.E., Montgomery P.S., Scott K.J., Blevins S.M. Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication. A randomized controlled trial. Circulation 2011, 123:491-498.
51. Schlager O., Giurgea A., Schuhfrid O., Seidinger D., Hammer A., Groger M., et al. Exercise training increases endothelial progenitor cells and decreases asymmetric dimethylarginine in peripheral arterial disease: a randomized controlled trial. Atherosclerosis 2011, 240-248.
52. Duscha B.D., Robbins J.L., Jones W.S., Kraus W.E., Lye R.J., Sanders J.M., et al. Angiogenesis in skeletal muscle precede improvement in peak oxygen uptake in peripheral artery disease patients. Arterioscler Thromb Vasc Biol 2011, 31:2742-2748.
53. Chen S.L., Fang W.W., Quian J., Ye F., Liu Y.H., Shan S.J., et al. Improvement of cardiac function after transplantation of autologous bone marrow mesenchymal stem cells in patients with acute myocardial infarction. Chin Med J 2004, 117:1443-1448.
54. Kueth F., Richartz B.M., Kasper C., Sayer H.G., Hoeffken K., Werner G.S., et al. Autologous intracoronary mononuclear bone marrow cell transplantation in chronic ischemic cardiomyopathy in humans. Int J Cardiol 2005, 100:485-491.
55. Pasquet S., Sovalat H., Henon P., Bischoff N., Arkam Y., Ojeda-Uribe M., et al. Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct. Cytotherapy 2009, 11:1002-1015.
56. Gardner A.W., Montgomery P.S., Parker D.E. Optimal exercise program length for patients with claudication. J Vasc Surg 2012, 55:1346-1354.